CoChat

The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well‐defined cohort

Open access
van Iersel, Laura, Meijneke, Ruud W.H., Schouten‐van Meeteren, Antoinette Y.N., Reneman, Liesbeth, de Win, Maartje M., van Trotsenburg, A.S. Paul, Bisschop, Peter H., Finken, Martijn J.J., Vandertop, W. Peter, van Furth, Wouter R., van Santen, Hanneke M. · 2018 · Pediatric Blood & Cancer
Cited by 33

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background: Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (CP). The influence of degree of resection on development of HO, event‐free survival (EFS), and neuroendocrine sequelae is an issue of debate. Procedure: A retrospective cohort consisting of all CP patients treated between 2002 and 2012 in two university hospitals was identified. Multivariable logistic regression was used to study the associations between preoperative BMI, age at diagnosis, tumor volume, performed surgical resection, and presence of HO at follow‐up. Results: Thirty‐five patients (21 children and 14 adults) were included. Median follow‐up time was 35.6 months (4.1–114.7). Four patients were obese at diagnosis. HO was present in 19 (54.3%) patients at last follow‐up of whom eight were morbidly obese. Thirteen (37.1%) patients underwent partial resection (PR) and 22 (62.9%) gross total resection (GTR). GTR was related to HO (OR 9.19, 95% CI 1.43–59.01), but for morbid HO, obesity at diagnosis was the only risk factor (OR 12.92, 95% CI 1.05–158.73). EFS in patients after GTR was 86%, compared to 42% after PR (log‐rank 9.2, P = 0.003). Adjuvant radiotherapy after PR improved EFS (log‐rank 8.2, P = 0.004). Panhypopituitarism, present in 15 patients, was mainly seen after GTR. Conclusions: HO is less frequent after PR than after GTR, but PR cannot always prevent the development of morbid obesity in patients with obesity at diagnosis. PR reduces the occurrence of panhypopituitarism. When developing a treatment algorithm, all these factors should be considered.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pbc.26911

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 33

Metadata

Authors
van Iersel, L., Meijneke, R. W. H., Schouten‐van Meeteren, A. Y. N., Reneman, L., de Win, M. M., van Trotsenburg, A. S. P., Bisschop, P. H., Finken, M. J. J., Vandertop, W. P., van Furth, W. R., & van Santen, H. M.
Venue
Pediatric Blood & Cancer
Publisher
Wiley
Published
2018-01-04
Volume
65
Issue
5
Pages
e26911-e26911
ISSN
  • 1545-5009 (ISSN-L)
  • 1545-5017
OpenAlex
W2782088961
Cited by
33
References
3
FWCI
1.71
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well‐defined cohort. https://app.cochat.ai/papers/10.1002/pbc.26911
The paper
van Iersel, L., Meijneke, R. W. H., Schouten‐van Meeteren, A. Y. N., Reneman, L., de Win, M. M., van Trotsenburg, A. S. P., Bisschop, P. H., Finken, M. J. J., Vandertop, W. P., van Furth, W. R., & van Santen, H. M. (2018). The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well‐defined cohort. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.26911

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.